Cytosorbents Corporation

Cytosorbents Corporation

Market Cap (Mar-08-2026)
0.05 Billion USD
World Rank (Jan-05-2024)
24,745
Market Cap (Jan-05-2024)
0.052 Billion USD
World Rank (Jul-30-2023)
19,097
Market Cap (Jul-30-2023)
0.165 Billion USD
World Rank (Jan-07-2022)
20,123
Market Cap (Jan-07-2022)
0.163 Billion USD
World Rank (Jan-01-2021)
13,023
Market Cap (Jan-01-2021)
0.344 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
CTSO
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
41 Million USD
Annual Net Income in USD
-9 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Healthcare Service
Medical Equipment / Instruments
Company Website
CYTOSORBENTS CORPORATION
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile
CytoSorbents Corporation is a U.S. company focused on treating life threatening conditions in the ICU and cardiac surgery using blood purification. It has more than 1,31,000 human treatments to date. The company annual revenue is 42.9 million USD and 125 employees as on 2020. The headquarters is in USA.
Founded Year
1997
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share